奇点网|PD-1抗体的半衰期与疗效之间的关系,没你想象的那么简单( 五 )


[11].信迪利单抗(Sintilimab) 说明书.
[13].阿维鲁单抗(Avelumab)说明书.
[14].Postow MA, et al. Immune-Related Adverse Events Associated with Immune Checkpoint Blockade.N Engl J Med 2018;378:158-168
[15].Sasikumar pottayil et al. A novel peptide therapeutic targeting PD1 immune checkpoint with equipotent antagonism of both ligands and a potential for better management of immune-related adverse eventsJournal for ImmunoTherapy of Cancer 2013, 1(Suppl 1):O24
[16].The NCCN Non-Small Cell Lung Cancer clinical practice guidelines in oncology (version 1.2020)
奇点网|PD-1抗体的半衰期与疗效之间的关系,没你想象的那么简单
本文插图